Dr. David Siegel featured in The Wall Street Journal

In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life expectancy for patients with the blood cancer.

Dr. Siegel, one of the nation’s foremost authorities on multiple myeloma, shares his thoughts in an article from The Wall Street Journal.  

David S. Siegel, M.D., Ph.D., is Chief of the Myeloma Division at John Theurer Cancer Center in Hackensack, N.J.

To read the full article…